IVF市场规模、份额、成长分析（按产品类型、按产品、按类型、按设备、按最终用户、按地区）- 产业预测 2025-2032

2023 年 IVF 市场规模价值为 268 亿美元，预计将从 2024 年的 290.5 亿美元成长到 2032 年的 553.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.4%。

全球体外受精（IVF）市场（包括辅助生殖技术）作为解决不孕症问题的方法已获得显着发展，使夫妻能够透过体外受精过程受孕。由于生活方式的改变、受孕延迟和各种健康状况导致不孕不育率上升，试管受精为那些面临自然受孕挑战的人们带来了希望。持续的技术进步，包括改进的实验室技术、基因检测和改进的胚胎选择，正在提高成功率并吸引寻求可靠不孕症解决方案的夫妻。体外受精 (IVF) 的需求正在快速增长，尤其是在新兴市场，人们的意识和可及性的提高推动了市场的成长。儘管这种治疗存在精神和身体上的障碍，但新的技术创新和改善的患者体验为 IVF 领域的扩展带来了良好的机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析

IVF 市场规模（依产品类型及复合年增长率）(2025-2032)

• 市场概览
• 新捐款者
• 新的非捐赠者
• 冻结捐赠者
• 冷冻非捐赠者

体外受精市场规模：依产品及复合年增长率（2025-2032）

• 市场概览
• 装置
  • 精子分析系统
  • 影像系统
  • 卵子吸泵
  • 微作业系统
  • 培养箱
  • 气体分析仪
  • 雷射系统
  • 低温系统
  • 精子分离装置
  • 试管婴儿柜
  • 防震台
  • 证人制度
  • 其他设备
• 试剂和培养基
  • 冷冻保存液
  • 胚胎培养基
  • 卵子处理介质
  • 精子处理培养基
• 配件

IVF 市场规模（按类型及复合年增长率）(2025-2032)

• 市场概览
• 传统试管婴儿
• 体外受精及显微授精
• 捐卵子试管婴儿
• 其他的

体外受精市场规模：依设备及复合年增长率（2025-2032）

• 市场概览
• 文化传媒
• 免洗设备
• 资本设备

IVF 市场规模（依最终用户和复合年增长率）(2025-2032)

• 市场概览
• 不孕不育诊所
• 手术中心
• 医院
• 研究机构

体外受精市场规模：依地区及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Ferring Pharmaceuticals（Switzerland）
• Merck KGaA（Germany）
• Cook Medical（USA）
• Vitrolife AB（Sweden）
• CooperSurgical, Inc.（USA）
• Ovascience, Inc.（USA）
• Irvine Scientific（USA）
• Genea Limited（Australia）
• Origio A/S（Denmark）
• Thermo Fisher Scientific Inc.（USA）
• Esco Medical ApS（Denmark）
• Nidacon International AB（Sweden）
• Boston IVF（USA）
• Virtus Health（Australia）
• Bloom Fertility Centre（India）
• Rainbow IVF（India）
• IVI RMA Global（Spain）
• CHA Healthcare（South Korea）
• Reproductive Medicine Associates of New Jersey（RMANJ）（USA）
• TSLC Corporation（Japan）

结论和建议

In Vitro Fertilization Market size was valued at USD 26.8 billion in 2023 and is poised to grow from USD 29.05 billion in 2024 to USD 55.39 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global In Vitro Fertilization (IVF) market, encompassing assisted reproductive technologies, has gained significant traction as a solution for infertility, enabling couples to conceive through external fertilization processes. With rising infertility rates attributed to lifestyle changes, late pregnancies, and various health conditions, IVF offers hope to those facing challenges in natural conception. Continuous technological advancements, including enhanced laboratory techniques, genetic testing, and improved embryo selection, have boosted success rates, attracting more couples seeking reliable fertility solutions. The demand for IVF is particularly surging in developing regions, where increased awareness and access are driving market growth. Despite the emotional and physical hurdles associated with the treatment, emerging innovations and improving patient experiences present promising opportunities for expansion in the IVF sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

In Vitro Fertilization Market Segments Analysis

Global In Vitro Fertilization Market is segmented by Product Type, Product, Type, Instrument, End User and region. Based on Product Type, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor and Frozen Non-Donor. Based on Product, the market is segmented into Equipment, Reagents & Media and Accessories. Based on Type, the market is segmented into Conventional IVF, IVF with ICSI, IVF with Donar Eggs and Others. Based on Instrument, the market is segmented into Culture Media, Disposable Devices and Capital Equipment. Based on End User, the market is segmented into Fertility Clinics, Surgical Centers, Hospitals and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market has experienced considerable growth due to remarkable advancements in reproductive technologies observed in 2021. Notably, the implementation of time-lapse imaging systems revolutionized the monitoring process for embryo development by enabling continuous observation. This innovation facilitated better selection of embryos, ultimately resulting in enhanced success rates for IVF procedures. As a result, these technological improvements have encouraged an increasing number of individuals and couples to pursue IVF treatments, thereby driving the overall demand and expansion of the IVF market in recent years.

Restraints in the In Vitro Fertilization Market

The financial burden of In Vitro Fertilization (IVF) treatments has been a considerable constraint, particularly noted in 2021. The high costs associated with medication, laboratory procedures, and the need for several treatment cycles can be overwhelming. This significant expense often renders IVF unattainable for many individuals and couples, especially those lacking sufficient financial means or insurance coverage. As a result, the affordability of these essential reproductive services remains a major barrier, limiting access for those who might benefit from such treatments and hindering their ability to pursue family planning options effectively.

Market Trends of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market is witnessing a notable trend towards the rising demand for genetic testing, particularly techniques like preimplantation genetic testing (PGT). In 2022, the integration of PGT into IVF procedures gained momentum as more couples sought to enhance their chances of successful pregnancies while minimizing the risk of genetic disorders in their future children. This shift is driven by increased awareness of genetic health and advancements in testing technologies, making it a critical factor in reproductive planning. As a result, IVF clinics are increasingly adopting these innovative genetic testing methods, reflecting a broader market trend that favors personalized and health-conscious fertility solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global In Vitro Fertilization Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

Global In Vitro Fertilization Market Size by Product & CAGR (2025-2032)

• Market Overview
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other Equipments
• Reagents & Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Accessories

Global In Vitro Fertilization Market Size by Type & CAGR (2025-2032)

• Market Overview
• Conventional IVF
• IVF with ICSI
• IVF with Donar Eggs
• Others

Global In Vitro Fertilization Market Size by Instrument & CAGR (2025-2032)

• Market Overview
• Culture Media
• Disposable Devices
• Capital Equipment

Global In Vitro Fertilization Market Size by End User & CAGR (2025-2032)

• Market Overview
• Fertility Clinics
• Surgical Centers
• Hospitals
• Research Institutes

Global In Vitro Fertilization Market Size & CAGR (2025-2032)

• North America (Product Type, Product, Type, Instrument, End User)
  • US
  • Canada
• Europe (Product Type, Product, Type, Instrument, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Product, Type, Instrument, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Product, Type, Instrument, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Product, Type, Instrument, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ovascience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Irvine Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Origio A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidacon International AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston IVF (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virtus Health (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom Fertility Centre (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rainbow IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVI RMA Global (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CHA Healthcare (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reproductive Medicine Associates of New Jersey (RMANJ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSLC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations